EMEA-002138-PIP01-17

Key facts

Invented name
Active substance
Carotuximab
Therapeutic area
Oncology
Decision number
P/0383/2017
PIP number
EMEA-002138-PIP01-17
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of soft tissue sarcoma
Route(s) of administration
Intravenous use
Contact for public enquiries
TRACON Pharma Limited
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating